Harvard Bioscience, Inc.HBIONASDAQ

Revenue (LTM)

$87M

-8.1% YoY

Net Income (LTM)

$-57M

-357.1% YoY

Free Cash Flow

$6M

Revenue CAGR (5Y)

-3.3%

—Marginsstable

FCFTurned positive

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	119	113↓4.7%	112↓1.0%	94↓16.1%	87↓8.1%
Gross Profit	68	61↓10.1%	66↑8.6%	55↓17.1%	46↓16.2%
Operating Income	2	-7↓435.6%	2↑127.3%	-6↓427.9%	-1↑89.9%
Net Income	-0	-10↓3204.2%	-3↑64.1%	-12↓263.3%	-57↓357.1%
EBITDA	9	1↓89.5%	8↑751.0%	-1↓118.3%	5↑460.7%
EPS Diluted	-0.07	-2.30↓3139.4%	-0.81↑65.0%	-2.80↓247.8%	-12.80↓357.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	8	5↓42.4%	4↓5.0%	4↓4.1%	9↑109.7%
Total Current Assets	62	51↓17.0%	49↓4.1%	45↓8.0%	48↑6.9%
Total Assets	162	145↓10.5%	137↓5.5%	127↓7.8%	80↓36.8%
Total Current Liabilities	25	23↓8.2%	27↑14.2%	55↑107.1%	22↓60.0%
Total Liabilities	79	73↓7.4%	64↓12.1%	63↓1.5%	66↑4.8%
Total Equity	83	72↓13.4%	73↑1.2%	63↓13.3%	14↓78.3%
Total Debt	57	54↓4.8%	43↓21.1%	44↑4.0%	44↓0.5%
Net Debt	49	50↑1.2%	38↓22.6%	40↑4.9%	36↓11.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	1	1↓8.7%	14↑1117.7%	1↓89.7%	7↑367.3%
Capital Expenditure	-1	-2↓18.2%	-2↓45.3%	-3↓41.2%	-1↑65.9%
Free Cash Flow	-0	-0↓427.7%	12↑2775.1%	-2↓115.6%	6↑408.0%
Stock-Based Comp	4	4↑5.8%	5↑13.4%	4↓13.2%	-2↓138.5%
Net Change in Cash	-0	-3↓567.9%	-0↑93.2%	-0↑22.2%	5↑2674.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance